Although relevant studies regarding CD93 regulating angiogenesis in SSc are scarce, a recent study showed that the serum soluble CD93 (sCD93) levels in patients with SSc having a disease duration <6 years were significantly higher [35]. The gene discussed is CD93; the disease is systemic sclerosis.